David Bergeron
InvestorAdvisory Partner, Advanced Technologies at Rev1 Ventures
Deals · 4
Super-H AnalyticsBoard seat
via Rev1 Ventures · filed Dec 2017 · $1.5M raise
ZeoVationBoard seat
via Rev1 Ventures · filed May 2017 · $800K raise
3Bar BiologicsBoard seat
via Rev1 Ventures · filed Apr 2017 · $2M raise
Med-Compliance IQBoard seat
via Rev1 Ventures · filed Sep 2016 · $430K raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Rev1 Ventures
Alicia Oddi
Managing Director, Venture Services at Rev1 Ventures
Amy Taylor
Board of Directors; President, Downtown Columbus, Inc. at Rev1 Ventures
Amy Whetsell
Executive Administrator at Rev1 Ventures
Andrea Ewing
Director, Corporate Partnerships at Rev1 Ventures
Andrea O'Carroll
Managing Director, Venture Platform at Rev1 Ventures
Andrea O’Carroll
Managing Director, Venture Platform at Rev1 Ventures
Avi Jayaraman
Seae Ventures Fellow at Seae Ventures
Brian Brohman
Life Sciences Advisory Partner at Rev1 Ventures
Frequently asked questions
- Who is David Bergeron?
- Advisory Partner, Advanced Technologies at Rev1 Ventures
- Where does David Bergeron work?
- David Bergeron is Advisory Partner, Advanced Technologies at Rev1 Ventures.
- What boards does David Bergeron sit on?
- David Bergeron holds tracked board seats at 3Bar Biologics, Med-Compliance IQ, Super-H Analytics, ZeoVation.